A. Tsianakas

发表

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.

C. Elmets, J. Scarisbrick, P. Zinzani, 2018, The Lancet. Oncology.

Efficacy and safety of the histamine H4 receptor antagonist ZPL‐3893787 in patients with atopic dermatitis

I. Osterloh, M. Yeadon, G. Layton, 2019, The Journal of allergy and clinical immunology.

Dupilumab treatment improves quality of life in adult patients with moderate‐to‐severe atopic dermatitis: results from a randomized, placebo‐controlled clinical trial

T. Luger, A. Tsianakas, A. Radin, 2018, The British journal of dermatology.

Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52‐week results from a Phase 3 double‐blind randomized, controlled trial

C. Bodemer, K. Kingo, A. Kaszuba, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator‐blinded, controlled, phase III study throughout Europe

B. Dréno, N. Basset-Seguin, V. von Felbert, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Efficacy and safety of canakinumab in Schnitzler syndrome: A multicenter randomized placebo‐controlled study

J. Fischer, M. Maurer, M. Church, 2017, The Journal of allergy and clinical immunology.

Content and value of rehabilitation in dermatology

A. Tsianakas, T. P. Voigt, Leonie Bause, 2021, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[Dermatological rehabilitation : Program content, opportunities and application submission].

A. Tsianakas, 2020, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

Rehabilitation in der Dermatologie

A. Tsianakas, 2020, Der Hautarzt.

Dermatoonkologische Rehabilitation

A. Tsianakas, Adam Muszynski, 2020, TumorDiagnostik & Therapie.

Rheumatoide Arthritis

A. Tsianakas, N. Magnolo, L. Bause, 2021, Der Hautarzt.

Secukinumab dosing optimization in patients with moderate‐to‐severe plaque psoriasis: results from the randomized, open‐label OPTIMISE study

K. Reich, J. Szepietowski, J. Szepietowski, 2020, The British journal of dermatology.

Minocycline Extended-Release Comparison with Doxycycline for the Treatment of Rosacea: A Randomized, Head-to-Head, Clinical Trial.

Srinivas H Shenoy, T. Pieber, A. Gautam, 2021, The Journal of clinical and aesthetic dermatology.

How important is subjective well-being for patients? A qualitative interview study of people with psoriasis

C. Blome, A. Tsianakas, R. Sommer, 2022, Quality of Life Research.

Dynamic Pruritus Score: Evaluation of the Validity and Reliability of a New Instrument to Assess the Course of Pruritus.

S. Ständer, M. Augustin, C. Blome, 2017, Acta dermato-venereologica.

Phase I/II study with trabedersen (AP 12009) monotherapy for the treatment of patients with advanced pancreatic cancer, malignant melanoma, and colorectal carcinoma.

A. Enk, A. Hauschild, C. Garbe, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dupilumab Use in Atopic Conditions and Its Side Effects

T. Luger, A. Tsianakas, 2017, Current Dermatology Reports.

A phase 2a proof of concept clinical trial to evaluate ZPL-3893787 (ZPL-389) a potent, oral histamine H4, receptor antagonist for the treatment of moderate to severe atopic dermatitis (AD) in adults

A. Nikkels, M. Yeadon, G. Layton, 2016 .

How important is subjective well-being for patients? A qualitative interview study of people with psoriasis

C. Blome, A. Tsianakas, R. Sommer, 2022, Quality of Life Research.

Dose‐escalation study evaluating pegylated interferon alpha‐2a in patients with cutaneous T‐cell lymphoma

R. Dummer, A. Hinke, W. Sterry, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

Dose-Escalation Study Evaluating Pegylated Interferon Alpha-2 a in Patients with Cutaneous T-Cell Lymphoma Running head : Pegylated IFN alpha-2 a in cutaneous T-cell lymphoma Names of authors :

A. Hinke, W. Sterry, R. Stadler, 2017 .

Comparison of pegylated interferon α‐2b plus psoralen PUVA versus standard interferon α‐2a plus PUVA in patients with cutaneous T‐cell lymphoma

S. Beissert, C. Loquai, D. Nashan, 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

The anti-IL-4 receptor alpha antibody dupilumab: facing a new era in treating atopic dermatitis

T. Luger, A. Tsianakas, 2015, Expert opinion on biological therapy.

The single‐chain anti‐TNF‐α antibody DLX105 induces clinical and biomarker responses upon local administration in patients with chronic plaque‐type psoriasis

T. Luger, M. Röcken, K. Ghoreschi, 2016, Experimental dermatology.

Response Of Rare Variants Of Cutaneous T Cell Lymphoma (CTCL) To Treatment With Bexarotene. A Prospective German DeCOG Trial

M. Weichenthal, U. Wehkamp, C. Klemke, 2013 .

Skin metastases in metastatic uveal melanoma: GNAQ/GNA11 mutational analysis as a valuable tool

N. Eter, A. Bräuninger, D. Metze, 2013, The British journal of dermatology.

Chromomycosis – successful CO2 laser vaporization

D. Metze, T. Luger, A. Tsianakas, 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.

Anti-pruritic Effect of Sertaconazole 2% Cream in Atopic Dermatitis Subjects: A Prospective, Randomized, Double-blind, Vehicle-controlled, Multi-centre Clinical Trial of Efficacy, Safety and Local Tolerability.

T. Luger, S. Ständer, M. Maurer, 2016, Acta dermato-venereologica.

Unmet Educational Needs and Clinical Practice Gaps in the Management of Generalized Pustular Psoriasis: Global Perspectives from the Front Line

B. Strober, M. Mockenhaupt, J. Seneschal, 2021, Dermatology and Therapy.

Personalized medicine : a world of opportunities in skin diseases

D. Metze, T. Luger, A. Tsianakas, 2008 .

Scalp necrosis in giant cell arteritis: case report and review of the relevance of this cutaneous sign of large-vessel vasculitis.

D. Presser, T. Luger, C. Sunderkoetter, 2009, Journal of the American Academy of Dermatology.

Transition of pityriasis lichenoides et varioliformis acuta to febrile ulceronecrotic Mucha–Habermann disease is associated with elevated serum tumour necrosis factor‐α

P. Hoeger, A. Tsianakas, 2005, The British journal of dermatology.

Exploratory Study of Intracutaneous Histamine Stimulation in Patient Populations with Chronic Pruritus.

S. Ständer, M. Schmelz, A. Tsianakas, 2019, Acta dermato-venereologica.

Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma.

R. Cowan, B. Dréno, S. Horwitz, 2020, Clinical lymphoma, myeloma & leukemia.

Chronic Prurigo of Nodular Type: A Review.

S. Ständer, G. Yosipovitch, M. Pereira, 2018, Acta dermato-venereologica.

Prurigo Nodularis Management.

S. Ständer, A. Tsianakas, C. Zeidler, 2016, Current problems in dermatology.

Management of cutaneous side effects of EGFR inhibitors: recommendations from a German expert panel for the primary treating physician

A. Enk, A. Hauschild, J. Becker, 2011, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Efficacy and safety of fumaric acid esters in young patients aged 10–17 years with moderate‐to‐severe plaque psoriasis: a randomized, double‐blinded, placebo‐controlled trial *

T. Gambichler, H. Hamm, A. Tsianakas, 2020, The British journal of dermatology.

Infantile‐onset cutaneous T‐cell lymphoma

P. Hoeger, A. Tsianakas, A. Kienast, 2008, The British journal of dermatology.

Immune Suppression via Glucocorticoid-Stimulated Monocytes: A Novel Mechanism To Cope with Inflammation

D. Bettenworth, J. Roth, K. Tenbrock, 2014, The Journal of Immunology.

Documentation of psoriasis in routine care – expert consensus on a German data set

W. Sondermann, B. Bonnekoh, R. Aschoff, 2021, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Long-term Efficacy of Canakinumab in the Treatment of Schnitzler Syndrome.

J. Fischer, M. Maurer, A. Tsianakas, 2020, The Journal of allergy and clinical immunology.

Induction of an anti-inflammatory human monocyte subtype is a unique property of glucocorticoids, but can be modified by IL-6 and IL-10.

T. Luger, J. Roth, G. Varga, 2012, Immunobiology.

The option of compassionate use in metastatic melanoma – way out of a therapeutic dilemma?

C. Sunderkötter, M. Schiller, A. Tsianakas, 2009, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Palmoplantar Pustulosis

R. Bissonnette, N. Bhakta, S. Baumgartner, 2021, Dermatology and Therapy.

Mutational analysis of GNAQ and GNA11 to aid therapy management of a choroidal melanoma metastatic to the contralateral orbit.

A. Bräuninger, A. Röpke, T. Spieker, 2013, JAMA ophthalmology.

Effectiveness and Tolerability of Ipilimumab: Experiences From 198 Patients Included in a Named-Patient Program in Various Daily-Practice Settings and Multiple Institutions

A. Hauschild, K. Kähler, C. Garbe, 2014, Journal of immunotherapy.

Adjuvant interferon therapy and rheumatoid arthritis – a contraindication?

T. Luger, C. Sunderkoetter, M. Schiller, 2009, Acta oncologica.

Anti-CCR4 Monoclonal Antibody, Mogamulizumab, Demonstrates Significant Improvement in PFS Compared to Vorinostat in Patients with Previously Treated Cutaneous T-Cell Lymphoma (CTCL): Results from the Phase III MAVORIC Study

C. Elmets, J. Scarisbrick, P. Zinzani, 2017 .

Prurigo nodularis – an update on an important disease

S. Ständer, A. Tsianakas, C. Zeidler, 2016 .